substances which lower blood glucose levels
5 statements, 1 sitelink - 21:54, 5 February 2024
They are widely used as [[antidiabetic drug]]s in the management of [[diabetes mellitus type 2]]. They act by incr
...increase the risk of hypoglycemia, and are contraindications. Since other antidiabetic drugs cannot be used either under these circumstances, insulin therapy is t
...
12 KB (1,572 words) - 20:36, 12 March 2024
* [[Antidiabetic/ja|抗糖尿病薬]]
...
9 KB (422 words) - 17:29, 25 March 2024
They are widely used as [[antidiabetic drug]]s in the management of [[diabetes mellitus type 2]]. They act by incr
...increase the risk of hypoglycemia, and are contraindications. Since other antidiabetic drugs cannot be used either under these circumstances, insulin therapy is t
...
12 KB (1,638 words) - 20:35, 12 March 2024
'''グリメピリド'''（'''Glimepiride'''）は、[[sulfonylurea/ja|スルホニルウレア薬]]クラスの[[antidiabetic medication/ja|抗糖尿病薬]]であり、主に[[type 2 diabetes/ja|2型糖尿病]]の管理に処方される。メトホルミンの安全性
...
8 KB (409 words) - 20:13, 14 March 2024
これらは[[diabetes mellitus type 2/ja|2型糖尿病]]の管理において[[antidiabetic drug/ja|抗糖尿病薬]]として広く使用されている。[[pancreas/ja|膵臓]]の[[beta cell/ja|β細胞]]からの[[ins
...
16 KB (476 words) - 08:59, 13 March 2024
* [[Antidiabetic]]
...
7 KB (907 words) - 10:49, 25 March 2024
* [[Antidiabetic]]
...
7 KB (941 words) - 10:47, 25 March 2024
'''Glimepiride''' is an [[antidiabetic medication]] within the [[sulfonylurea]] class, primarily prescribed for th
...
7 KB (812 words) - 22:54, 13 March 2024
'''Glimepiride''' is an [[antidiabetic medication]] within the [[sulfonylurea]] class, primarily prescribed for th
...
7 KB (848 words) - 22:53, 13 March 2024
...、腎臓でのグルコースの再吸収が低下し、血液循環中のグルコース濃度が高いほどグルコース排泄作用が増加する。したがって、ダパグリフロジンは、他の多くの[[antidiabetic drugs/ja|糖尿病治療薬]]とは異なり、インスリンの分泌や感受性に依存しない機序で血糖濃度を低下させる。機能的な膵臓の[[Beta cell/j
...
25 KB (941 words) - 09:18, 13 February 2024
...AACE]] rate sulfonylureas (as well as glinides) below all other classes of antidiabetic drugs in terms of suggested use as first, second, or third line agents - th
...n and headache, but both classes appear to present an alternative to other antidiabetic drugs. However, weight gain and/or hypoglycemia have been observed when [[d
...
27 KB (3,702 words) - 12:09, 4 February 2024
...insulin secretion and sensitivity, unlike many other [[antidiabetic drugs|antidiabetic medications]]. Functional pancreatic [[Beta cell|β-cell]]s are not necessar
...
21 KB (2,807 words) - 19:46, 12 February 2024
...antitumor]], [[hypoglycemic]], [[hypolipidemic]], [[wound healing]], and [[antidiabetic]] effects.{{R|"Radha2015"}}
...
9 KB (1,182 words) - 08:02, 4 January 2023
...AACE]] rate sulfonylureas (as well as glinides) below all other classes of antidiabetic drugs in terms of suggested use as first, second, or third line agents - th
...n and headache, but both classes appear to present an alternative to other antidiabetic drugs. However, weight gain and/or hypoglycemia have been observed when [[d
...
28 KB (3,821 words) - 16:44, 13 April 2024
...insulin secretion and sensitivity, unlike many other [[antidiabetic drugs|antidiabetic medications]]. Functional pancreatic [[Beta cell|β-cell]]s are not necessar
...
21 KB (2,899 words) - 19:46, 12 February 2024
...commonly associated with gastrointestinal adverse effects than most other antidiabetic medications. The most serious potential adverse effect of metformin is [[la
The [[biguanide]] class of antidiabetic medications, which also includes the withdrawn agents [[phenformin]] and [[
...
42 KB (5,783 words) - 19:35, 11 March 2024
...commonly associated with gastrointestinal adverse effects than most other antidiabetic medications. The most serious potential adverse effect of metformin is [[la
The [[biguanide]] class of antidiabetic medications, which also includes the withdrawn agents [[phenformin]] and [[
...
44 KB (5,999 words) - 19:35, 11 March 2024
== Combination with other antidiabetic drugs ==
A combination therapy of insulin and other [[antidiabetic drug]]s appears to be most beneficial in people who are diabetic, who still
...
57 KB (8,343 words) - 13:17, 21 March 2024
インスリンと他の[[antidiabetic drug/ja|抗糖尿病薬]]の併用療法は、インスリン分泌能が残存している糖尿病患者において最も有益と思われる。インスリン療法と[[sulfonylu
...
69 KB (1,887 words) - 11:33, 22 March 2024